This episode of Digital Pathology Today™ our guest is Michael Quick, Vice President, Research & Development / Innovation Hologic

Amidst this digital transformation in pathology the talk seems to be largely centered around whole slide imaging of H&E-stained tissue sections. But what about cytology? Why don't we hear much talk about digital cytology, and what are some of the unique challenges in cytology in terms of going digital.

We discuss the history and evolution of cervical cancer screening all the way from pap smears to thin prep to incorporating digital pathology and image analysis in the process. Will we finally be able to say goodbye to the light microscope? And what are some of the parallels and lessons learned comparing cervical cancer screening by cytology in pathology to breast cancer screening by digital mammography in radiology.

Michael Quick

Vice President, Research & Development / Innovation

Hologic

Mike is an executive leader with global experience in sales, marketing, distribution management, market development, international business management, new product development, and innovation. Strong professional skilled in Research and Development (R&D), U.S. Food and Drug Administration (FDA), Medical Devices, Disposables, and Business Development.